Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Nerac IPDex™
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Archives for Nerac Insights / Articles

Adverse Event Reporting: Pfizer, Inc. and Moderna, Inc. vs. Johnson & Johnson

By Ryan Rix, Nerac Analyst
Originally published June 3, 2021
This article looks at how the VAERS (Vaccine Adverse Event Reporting System) tracks adverse events and post market surveillance. Read more here.

Sample Research Report: Drug Product Literature Search and Review

By Richard Hendriks, Ph.D., Nerac Analyst
Originally published April 30, 2021
This sample report demonstrates Nerac’s approach to providing drug product literature search support. Read more here.

Sample Research Report: New Technologies in Contact Lenses

By Helga Weires, Nerac Analyst
Originally published March 15, 2021
This sample report demonstrates how an examination of both patent and technical literature can identify technologies creating disruption within the next 5-10 years, and help focus product development activities. Read more here.

Sample Custom Briefing – The Role of AI in Additive Manufacturing and Materials Development

By Jeffrey Magee, BSME, MBA, Nerac Analyst
Originally published Feb 27, 2021
This articles explores the interplay of tech innovation and patent activity with market and regulatory news to identify trends, game changers, and guide business actions. Read more here.

Anticipating the Need: Medical Devices for the Future

By Helga Weires, Nerac Analyst
Originally published February 12, 2021
This articles explores generational demographics and how to use that data to look at trends that can impact new product development. Read more here.

Acoustic Metamaterials: Are they the wave of the future?

By Rosemarie Szostak, Ph.D.
Originally published Jan 15, 2021
How do you identify potentially Disruptive Technologies in your market space? In an adjacent market space? How can you identify threats to your essential product portfolio or the potential benefit of acquiring or licensing outside IP to mitigate the disruptions? Learn more here.

Project Blue – A Connecticut Nexus of Economic Development, Scientific Research, and Marine Conservation

By Robert Beinstein, P.E., ENV SP, Director Sustainability Innovation
Originally published December 10, 2020
Initially focused on leveraging the fledgling Long Island Sound kelp/seaweed industry as a catalyst for growth, Project Blue’s leaders envision evolving this concept into a Blue Economy research, technology transfer, innovation, and business incubation hub in New Haven, CT, to be more succinctly known as the Long Island Sound Ocean Cluster, or LISOC. Read more here.

Inspiring Next: Purposeful Innovation

By Ripi Singh, Inspiring Next and Nerac Strategic Partner
Originally published December 10, 2020
The Nerac/Inspiring Next Purposeful Innovation workshop series is designed to bring innovation to your organization. Learn more here.

A World in Turmoil Creates Unprecedented Waves in the Business Climate

By Robert Beinstein, P.E., ENV SP, Director Sustainability Innovation
Originally published October 26, 2020
So much has been written as the Covid-19 pandemic as it continues its rampage through our world. As a result, businesses are trying to respond in ways that enables survival at a minimum, and prosperity in the best case. This article explores a sampling of input from some of the leading firms and offers a path to find the data that will be the lifeblood of any corporate recovery. Read more here.

Assessment of Digital Health Start-ups – Sample Research Report

By Nerac IP Analysts
Originally Published July 28, 2020
Changing industry demands and new business challenges are also offering unprecedented opportunity. This sample research report demonstrates our approach for a client looking to expand into a new market by acquiring a start-up or licensing existing IP. Read more here.

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 20
  • Next Page »
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation patenting patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting Tech Scouting XcellR8
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2023 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!

  • This field is for validation purposes and should be left unchanged.